Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 7, 2001, Pages 690-700

  Hojo, M ^a   Miwa, H ^a   Nagahara, A ^a   Sato, N ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Pooled eradication rate; Quadruple therapy; Ranitidine bismuth based triple therapy; Re eradication

Indexed keywords

12 SULFODEHYDROABIETIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; FAMOTIDINE; FURAZOLIDONE; LANSOPRAZOLE; METRONIDAZOLE; MINOCYCLINE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; RANITIDINE BISMUTH CITRATE; STOMACH SECRETION INHIBITOR; TETRACYCLINE; TINIDAZOLE;

ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034975928     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201300191941     Document Type: Article

References (71)

1. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori
2. What other regimens are under investigation to treat Helicobacter pylori infection?
3. Treatment of Helicobacter pylori infection: A review of the world literature
4. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection
5. Metronidazole, omeprazole and clarithromycin: An effective combination therapy for Helicobacter pylori infection
6. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study
7. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study
8. Current European concepts in the management of Helicobacter pylori infection. The Masstricht Consensus Report
9. Helicobacter pylori consensus. Report of the 1997 Asia Pacific consensus conference on the management of Helicobacter pylori infection
10. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy
11. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection
12. Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease
13. Therapeutic options after failed Helicobacter pylori eradication therapy
14. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients
15. The management of failed dual or triple therapy for Helicobacter pylori eradication
16. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication
17. One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy
18. Re-treatment after Helicobacter pylori eradication failure
19. Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori
20. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: Differing efficacy in previously treated and untreated patients
21. A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment
22. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy
23. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice
24. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: Omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole
25. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy
26. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: A detailed, prospective analysis of 21 consecutive cases
27. Retreatment of Helicobacter pylori infection with amoxycillin and omeprazole in patients failing this regime is less successful than initial treatment
28. Addition of metronidazole to omeprazole and amoxicillin for second line H. pylori eradication does not influence eradication rate: Results of a single-blinded randomised trial
29. Therapeutic options after failed H. pylori eradication therapy
30. Two step therapy for H. pylori eradication with lansoprazole, amoxicillin and a mucosal protective agent: Ecabet sodium
31. Randomised study on two second-line treatments after failed metronidazole-clarithromycin therapy
32. PPI-triple therapy failure in Helicobacter pylori (Hp) infection: Retreatment with PPI-triple therapy or quadruple therapy?
33. Effectiveness of 10 days omeprazole + clarithromycin + tinidazole (OCT) in patients who previously failed metronidazole based therapy
34. Triple therapy using ciprofloxacin for eradication of clarithromycin and metronidazole-resistant Helicobacter pylori
35. Efficacy of triple therapy to eradicate H. pylori after failure of omeprazole/amoxicillin
36. Rescue therapy after H. pylori treatment failure: Omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole
37. 'Rescue' therapy including ranitidine bismuth citrate (RBC) + minocycline (MIN) + amoxicillin (AMOX) for eradication of Helicobacter pylori (Hp) in previous Hp treatment failure
38. Ranitidine bismuth citrate (RBC)-based triple therapies for recurring Helicobacter pylori (Hp) eradication
39. Retreatment after failure of Helicobacter pylori eradication: Quadruple vs ranitidine bismuth citrate 2 weeks therapy
40. Two different approaches after failure of standard H. pylori eradication triple therapies
41. Ranitidine bismuthate citrate as a second step for the eradication of Helicobacter pylori
42. Clinical practice results of quadruple treatment in Helicobacter pylori eradication failure with OCA-7
43. Quadruple therapy with omeprazole, tetracycline, metronidazole, and bismuth as a second option after failure of a first eradication therapy
44. Maastricht consensus report regimen for second-line treatment of H. pylori infection: How does it perform in practice?
45. Randomized study comparing omeprazole (O) and ranitidine (R) as antisecretory agent in 'quad' therapy provided as a second choice treatment in patients with duodenal ulcer
46. Comparison of the efficacy of two quadruple therapies for Helicobacter pylori eradication in patients with primary treatment failure
47. Treatment with quadruple therapy after triple therapy failure in patients infected with H. pylori resistant strains
48. Randomized comparison of omeprazole (O) and ranitidine (R) when used for H. pylori (HP) eradication in 'quad' treatment (second line) of patients with erosive duodenitis (ED) or duodenal ulcer (DU)
49. High eradication rate of Helicobacter pylori (HP) in patients unsuccessfully treated previously
50. Intent to treat metronidazole resistant H. pylori infection to 100% of cure. Therapy with quadruple therapy and its modification
51. Eradication failure (EF) after H. pylori treatment-further therapies
52. Treatment after failure: The problem of 'non-responders'
53. Comparison of three seven days pantoprazole (PANTO) based Helicobacter pylori (Hp) eradication schemes in a Mexican population with highly metronidazole (MET) resistant Hp strains
54. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance
55. Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan
56. Factors influencing the eradication of Helicobacter pylori with triple therapy
57. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success
58. Patient factors affecting Helicobacter pylori eradication with triple therapy
59. Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori
60. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: A prospective, randomized, and controlled study
61. Omeprazole plus amoxicillin: Efficacy of various treatment regimens to eradicate Helicobacter pylori
62. Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori
63. Antibiotic-resistant H. pylori strains in the last ten years in Japan
64. Characteristics of anti-microbial agents and its clinical choice for H. pylori treatment
65. Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin
66. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: A study in peptic ulcer patients with omeprazole and amoxicillin
67. An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively
68. Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients
69. Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study
70. How to treat Helicobacter pylori infection - Should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint
71. Treatment of antibiotic-resistant Helicobacter pylori